SM

Sumatiprakash Madanlal Jain

Active Director Director DIN 01434599
DIN 01434599 First appointment Feb 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Feb 2004
Shareholding value •••• Premium profile

About Sumatiprakash Madanlal Jain

Data last updated:

Sumatiprakash Madanlal Jain is a Director at Creative Pharma Technologies Private Limited (since 2017) and Designated Partner at Fovero Healthcare Llp (since 2021). The companies operate in Pharma and FMCG. The largest current company by reported revenue is Creative Pharma Technologies Private Limited at ₹47.56 Cr (FY 2024). Earlier, Sumatiprakash Madanlal Jain was a Director at Viilbery Healthcare Private Limited (2019–2020) and Additional Director at Qualigens Pharma Private Limited (2016–2019) and 3 more.

DIN 01434599
Primary Designation Director
Industry Pharma
First Appointment 09 Feb 2004
Oldest Company Age 22 yrs
Largest company Creative Pharma Technologies Private Limited · ₹47.56 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Mar 20172017₹47.56 Cr (FY 2024)Active
Designated Partner10 Mar 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Viilbery Healthcare Private Limited U85100MH2008PTC184527
Director03 Jun 20192008₹1.41 Cr (FY 2023)Under Liquidation
Qualigens Pharma Private Limited U24100MH2013PTC249071
Additional Director10 Mar 20162013₹215 Cr (FY 2025)Active
Jinendra Qualipharm Private Limited U24100MH2009PTC196480
Director28 Oct 20092009₹24.30 Cr (FY 2025)Active
Cremed Labs Private Limited U24230MH2004PTC144430
Director09 Feb 20042004Strike Off
Creative Healthcare Private Limited U24230MH2005PTC154622
Managing Director08 Jul 20052005Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Sumatiprakash Madanlal Jain

Directorship timeline

Open interactive timeline →
Fovero Healthcare Llp
Cremed Labs Private Limited
Creative Healthcare Private Limited
Creative Pharma Technologies Private Limited
Premium access

Shareholding and investment profile for Sumatiprakash Madanlal Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumatiprakash Madanlal Jain

Sumatiprakash Madanlal Jain currently holds 2 directorships: Creative Pharma Technologies Private Limited (Director, since 10 Mar 2017, revenue ₹47.56 Cr (FY 2024)); Fovero Healthcare Llp (Designated Partner, since 10 Mar 2021).

Sumatiprakash Madanlal Jain was first appointed on 09 Feb 2004 as Director at Cremed Labs Private Limited. The most recent appointment on record is 10 Mar 2021 at Fovero Healthcare Llp.

Sumatiprakash Madanlal Jain held 5 earlier board appointments: Viilbery Healthcare Private Limited (Director, 03 Jun 2019 to 11 Aug 2020); Qualigens Pharma Private Limited (Additional Director, 10 Mar 2016 to 28 Feb 2019); Jinendra Qualipharm Private Limited (Director, 28 Oct 2009 to 28 Jan 2015); Cremed Labs Private Limited (Director, from 09 Feb 2004); Creative Healthcare Private Limited (Managing Director, from 08 Jul 2005).

The current boards of Sumatiprakash Madanlal Jain's companies include Mayank Sumatiprakash Jain (Creative Pharma Technologies Private Limited), Pawan Solanki (Creative Pharma Technologies Private Limited), Hardik Prakash Shah (Fovero Healthcare Llp), Nilay Bharatendu Pandya (Fovero Healthcare Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available